The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure

Lifetime Data Analysis

Volumn 24, Issue 3, 2018, Pages 425-442

  Nevo, Daniel ^a   Nishihara, Reiko ^a   Ogino, Shuji ^a,b,c   Wang, Molin ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Competing risks; Masked cause of failure; Missing at random; Subtype analysis

Indexed keywords

TUMOR MARKER;

ALGORITHM; BIOSTATISTICS; CAUSALITY; COLORECTAL TUMOR; HUMAN; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL BIAS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ALGORITHMS; BIAS; BIOMARKERS, TUMOR; BIOSTATISTICS; CAUSALITY; COLORECTAL NEOPLASMS; HUMANS; LIKELIHOOD FUNCTIONS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 85026802010     PISSN: 13807870     EISSN: 15729249     Source Type: Journal    
DOI: 10.1007/s10985-017-9401-8     Document Type: Article

References (30)

1. Bakoyannis G, Siannis F, Touloumi G (2010) Modelling competing risks data with missing cause of failure. Stat Med 29(30):3172–3185
2. Basu S, Sen A, Banerjee M (2003) Bayesian analysis of competing risks with partially masked cause of failure. J R Stat Soc Ser C (Appl Stat) 52(1):77–93
3. Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE (2013) A conceptual and methodological framework for investigating etiologic heterogeneity. Stat Med 32(29):5039–5052
4. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD et al (2010) Case–control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 102(6):391–400
5. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330–337
6. Chatterjee N, Sinha S, Diver WR, Feigelson HS (2010) Analysis of cohort studies with multivariate and partially observed disease classification data. Biometrika 97(3):683–698
7. Colussi D, Brandi G, Bazzoli F, Ricciardiello L (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14(8):16,365–16,385
8. Cox DR (1972) Regression models and life-tables. J R Stat Soc Ser B (Methodol) 34(2):187–220
9. Craiu RV, Duchesne T (2004) Inference based on the EM algorithm for the competing risks model with masked causes of failure. Biometrika 91(3):543–558
10. Dewanji A (1992) A note on a test for competing risks with missing failure type. Biometrika 79(4):855–857
11. Flehinger BJ, Reiser B, Yashchin E (2002) Parametric modeling for survival with competing risks and masked failure causes. Lifetime Data Anal 8(2):177–203
12. Gao G, Tsiatis AA (2005) Semiparametric estimators for the regression coefficients in the linear transformation competing risks model with missing cause of failure. Biometrika 92(4):875–891
13. Goetghebeur E, Ryan L (1995) Analysis of competing risks survival data when some failure types are missing. Biometrika 82(4):821–833
14. Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, Hopper JL, Southey MC, Young JP, Buchanan DD, Walsh MD et al (2012) Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 41(4):1060–1072
15. Hyun S, Lee J, Sun Y (2012) Proportional hazards model for competing risks data with missing cause of failure. J Stat Plan Inference 142(7):1767–1779
16. Kalbfleisch JD, Prentice RL (2011) The statistical analysis of failure time data, vol 360. Wiley, New York
17. Kocarnik JM, Shiovitz S, Phipps AI (2015) Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep 3(4):269–276
18. Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T (2015) Colorectal cancer. Nat Rev Dis Primers 1:15,065 EP. doi:10.1038/nrdp.2015.65
19. Lu W, Liang Y (2008) Analysis of competing risks data with missing cause of failure under additive hazards model. Stat Sin 18(1):219–234
20. Lu K, Tsiatis AA (2001) Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure. Biometrics 57(4):1191–1197
21. Lu K, Tsiatis AA (2005) Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure. Lifetime Data Anal 11(1):29–40
22. Moreno-Betancur M, Latouche A (2013) Regression modeling of the cumulative incidence function with missing causes of failure using pseudo-values. Stat Med 32(18):3206–3223
23. Nevo D, Zucker DM, Tamimi RM, Wang M (2016) Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor data. Stat Med 35(30):5686–5700
24. Ogino S, Stampfer M (2010) Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst 102(6):365–367
25. Ogino S, Chan AT, Fuchs CS, Giovannucci E (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60(3):397–411
26. Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H et al (2016) The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 27(4):602–611
27. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell V, Breslow N (1978) The analysis of failure times in the presence of competing risks. Biometrics 43(4):541–554
28. Sen A, Banerjee M, Li Y, Noone AM (2010) A Bayesian approach to competing risks analysis with masked cause of death. Stat Med 29(16):1681–1695
29. Wang M, Kuchiba A, Ogino S (2015) A meta-regression method for studying etiological heterogeneity across disease subtypes classified by multiple biomarkers. Am J Epidemiol 182(3):263–270
30. Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S (2016) Statistical methods for studying disease subtype heterogeneity. Stat Med 35(5):782–800. doi:10.1002/sim.6793